Zulfiya Syunyaeva

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.

Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.

Journal: The European respiratory journal

Published: January 23, 2025

The established chest MRI score for cystic fibrosis can be applied to contrast agent-free matrix pencil decomposition functional MRI: a multireader analysis.

The established chest MRI score for cystic fibrosis can be applied to contrast agent-free matrix pencil decomposition functional MRI: a multireader analysis.

Journal: Frontiers in medicine

Published: November 13, 2024

Cystic fibrosis in childhood and adulthood

Cystic fibrosis in childhood and adulthood

Journal: Innere Medizin (Heidelberg, Germany)

Published: April 24, 2024

Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy.

Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: April 07, 2024

Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis.

Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 24, 2023

Risk of pneumothorax in Birt-Hogg-Dubé syndrome during pregnancy and birth.

Risk of pneumothorax in Birt-Hogg-Dubé syndrome during pregnancy and birth.

Journal: Frontiers in medicine

Published: September 06, 2023

Correction to: The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.

Correction to: The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.

Journal: BMC palliative care

Published: May 10, 2023

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis.

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis.

Journal: Frontiers in pharmacology

Published: March 03, 2023

Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study.

Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study.

Journal: Infection

Published: July 07, 2022

The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.

The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.

Journal: BMC palliative care

Published: June 14, 2022

Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases.

Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: February 26, 2022

Delayed diagnosis of Birt-Hogg-Dubé syndrome might be aggravated by gender bias.

Delayed diagnosis of Birt-Hogg-Dubé syndrome might be aggravated by gender bias.

Journal: EClinicalMedicine

Published: February 08, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026